This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (5) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Rahman, A Articles by Potter, K N Search for Related Content PubMed PubMed Citation Articles by Rahman, A Articles by Potter, K N Pubmed/NCBI databases Medline Plus Health Information Lupus Social Bookmarking                         What's this?

Anti-DNA antibodies—structure and function

Centre for Rheumatology, Department of Medicine, University College London, UK; and 2Tenovus Research Laboratory, Southampton General Hospital, Southampton, UK, Centre for Rheumatology, Arthur Stanley House, 40–50 Tottenham Street, London W1T 4NJ, UK. anisur.rahman{at}uclac.uk

S Kumar

Centre for Rheumatology, Department of Medicine, University College London, UK

K N Potter

Tenovus Research Laboratory, Southampton General Hospital, Southampton, UK

Expression of monoclonal anti-DNA antibodies in vitro can be used to study the relationships between molecular structure, binding properties and pathogenicity.Bacterial and yeast systems can be used to produce antibody fragments such as Fab. The yields are potentially sufficient to allow structural studies such as crystallization, but purification of the anti-DNA Fab from the bacterial periplasm may be challenging. Mammalian cell expression systems produce lower yields, but the products are whole antibodies, which can be used in assays of pathogenicity. This article describes some recent experiments in which bacterial and mammalian systems were used to study human monoclonal anti-DNA antibodies. Light chain sequence motifs were found to be important both in binding to antigens and in determining pathogenicity of the antibodies in severe combined immunodeficiency mice. The distribution of B cell subpopulations is disturbed in patients with systemic lupus erythematosus (SLE). These patients, like those with infectious mononucleosis, have an overall B cell lymphopenia but an increased frequency of plasmablasts/early plasma cells in their blood. Some of these early plasma cells belong to clones that have rearranged the V_H gene V4-34. There is a selective rise in immunoglobulins encoded by this gene in both infectious mononucleosis and SLE.

Key Words: systemic lupus erythematosus • expression systems • plasma cells • infectious mononucleosis

Lupus, Vol. 11, No. 12, 776-779 (2002)
DOI: 10.1191/0961203302lu315oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				F Martinez-Valle, E Balada, J Ordi-Ros, S Bujan-Rivas, A Sellas-Fernandez, and M Vilardell-Tarres DNase 1 activity in patients with systemic lupus erythematosus: relationship with epidemiological, clinical, immunological and therapeutical features Lupus, April 1, 2009; 18(5): 418 - 423. [Abstract] [PDF]